Chronotropic incompetence is more frequent in obese adolescents and relates to systemic inflammation and exercise intolerance.
Adolescents
Cardiometabolic health
Exercise tolerance
Heart rate
Obesity
Journal
Journal of sport and health science
ISSN: 2213-2961
Titre abrégé: J Sport Health Sci
Pays: China
ID NLM: 101606001
Informations de publication
Date de publication:
03 2023
03 2023
Historique:
received:
23
09
2020
revised:
18
11
2020
accepted:
08
12
2020
medline:
4
4
2023
pubmed:
3
2
2021
entrez:
2
2
2021
Statut:
ppublish
Résumé
Adults with obesity may display disturbed cardiac chronotropic responses during cardiopulmonary exercise testing, which relates to poor cardiometabolic health and an increased risk for adverse cardiovascular events. It is unknown whether cardiac chronotropic incompetence (CI) during maximal exercise is already present in obese adolescents and, if so, how that relates to cardiometabolic health. Sixty-nine obese adolescents (body mass index standard deviation score = 2.23 ± 0.32, age = 14.1 ± 1.2 years; mean ± SD) and 29 lean adolescents (body mass index standard deviation score = -0.16 ± 0.84, age = 14.0 ± 1.5 years) performed a maximal cardiopulmonary exercise testing from which indicators for peak performance were determined. The resting heart rate and peak heart rate were used to calculate the maximal chronotropic response index. Biochemistry (lipid profile, glycemic control, inflammation, and leptin) was studied in fasted blood samples and during an oral glucose tolerance test within obese adolescents. Regression analyses were applied to examine associations between the presence of CI and blood or exercise capacity parameters, respectively, within obese adolescents. CI was prevalent in 32 out of 69 obese adolescents (46%) and 3 out of 29 lean adolescents (10%). C-reactive protein was significantly higher in obese adolescents with CI compared to obese adolescents without CI (p = 0.012). Furthermore, peak oxygen uptake and peak cycling power output were significantly reduced (p < 0.05) in obese adolescents with CI vs. obese adolescents without CI. The chronotropic index was independently related to blood total cholesterol (standardized coefficient β = -0.332; p = 0.012) and C-reactive protein concentration (standardized coefficient β = -0.269; p = 0.039). CI is more common in the current cohort of obese adolescents, and is related to systemic inflammation and exercise intolerance.
Sections du résumé
BACKGROUND
Adults with obesity may display disturbed cardiac chronotropic responses during cardiopulmonary exercise testing, which relates to poor cardiometabolic health and an increased risk for adverse cardiovascular events. It is unknown whether cardiac chronotropic incompetence (CI) during maximal exercise is already present in obese adolescents and, if so, how that relates to cardiometabolic health.
METHODS
Sixty-nine obese adolescents (body mass index standard deviation score = 2.23 ± 0.32, age = 14.1 ± 1.2 years; mean ± SD) and 29 lean adolescents (body mass index standard deviation score = -0.16 ± 0.84, age = 14.0 ± 1.5 years) performed a maximal cardiopulmonary exercise testing from which indicators for peak performance were determined. The resting heart rate and peak heart rate were used to calculate the maximal chronotropic response index. Biochemistry (lipid profile, glycemic control, inflammation, and leptin) was studied in fasted blood samples and during an oral glucose tolerance test within obese adolescents. Regression analyses were applied to examine associations between the presence of CI and blood or exercise capacity parameters, respectively, within obese adolescents.
RESULTS
CI was prevalent in 32 out of 69 obese adolescents (46%) and 3 out of 29 lean adolescents (10%). C-reactive protein was significantly higher in obese adolescents with CI compared to obese adolescents without CI (p = 0.012). Furthermore, peak oxygen uptake and peak cycling power output were significantly reduced (p < 0.05) in obese adolescents with CI vs. obese adolescents without CI. The chronotropic index was independently related to blood total cholesterol (standardized coefficient β = -0.332; p = 0.012) and C-reactive protein concentration (standardized coefficient β = -0.269; p = 0.039).
CONCLUSION
CI is more common in the current cohort of obese adolescents, and is related to systemic inflammation and exercise intolerance.
Identifiants
pubmed: 33529767
pii: S2095-2546(21)00019-3
doi: 10.1016/j.jshs.2021.01.010
pmc: PMC10105027
pii:
doi:
Substances chimiques
C-Reactive Protein
9007-41-4
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
194-201Informations de copyright
Copyright © 2021. Production and hosting by Elsevier B.V.
Références
J Clin Endocrinol Metab. 2003 Mar;88(3):1019-23
pubmed: 12629079
Phys Ther. 2016 Jun;96(6):850-64
pubmed: 26637641
Circulation. 2011 Mar 8;123(9):1010-20
pubmed: 21382903
Nutr Metab Cardiovasc Dis. 2009 Mar;19(3):170-6
pubmed: 18804987
Sports Med. 2015 Jul;45(7):985-95
pubmed: 25834997
Z Kardiol. 1994;83 Suppl 3:1-12
pubmed: 7941654
Eur J Nutr. 2003 Aug;42(4):181-7
pubmed: 12923648
J Clin Endocrinol Metab. 2004 Mar;89(3):1096-101
pubmed: 15001593
J Clin Endocrinol Metab. 1994 Jun;78(6):1331-5
pubmed: 8200934
J Appl Physiol (1985). 1986 Jun;60(6):2020-7
pubmed: 3087938
Lancet. 2017 Dec 16;390(10113):2627-2642
pubmed: 29029897
Pediatrics. 2013 Dec;132(6):1098-104
pubmed: 24249816
BMJ. 1990 Jan 27;300(6719):230-5
pubmed: 2106931
Stat Med. 1992 Jul;11(10):1305-19
pubmed: 1518992
Obesity (Silver Spring). 2011 Sep;19(9):1813-7
pubmed: 21681223
J Anat. 1993 Oct;183 ( Pt 2):277-89
pubmed: 7507911
Eur Heart J. 2006 Apr;27(8):897-8
pubmed: 16551652
Obes Rev. 2014 Nov;15(11):894-904
pubmed: 25132188
Int J Obes Relat Metab Disord. 2000 Jun;24 Suppl 2:S89-91
pubmed: 10997618
J Clin Endocrinol Metab. 2009 Oct;94(10):3687-95
pubmed: 19584191
Arch Dis Child. 1969 Jun;44(235):291-303
pubmed: 5785179
N Engl J Med. 1982 Jul 22;307(4):205-11
pubmed: 6283349
N Engl J Med. 2005 May 12;352(19):1951-8
pubmed: 15888695
Int J Obes (Lond). 2019 Jul;43(7):1400-1410
pubmed: 30568263
Arch Public Health. 2014 Dec 24;72(1):47
pubmed: 25671114
J Cardiopulm Rehabil Prev. 2014 May-Jun;34(3):202-7
pubmed: 24481127
J Sports Med Phys Fitness. 2017 Dec;57(12):1687-1694
pubmed: 27763583
Oxid Med Cell Longev. 2013;2013:174782
pubmed: 23691262
Int J Cardiol. 2013 Oct 3;168(3):2347-51
pubmed: 23416017
Chest. 1992 Mar;101(3):674-9
pubmed: 1541131
Int J Obes (Lond). 2020 Jun;44(6):1376-1386
pubmed: 32203114
Am J Clin Nutr. 1996 Sep;64(3 Suppl):436S-448S
pubmed: 8780360
Best Pract Res Clin Endocrinol Metab. 2013 Apr;27(2):229-38
pubmed: 23731884
Arch Dis Child. 1970 Feb;45(239):13-23
pubmed: 5440182
Circulation. 1989 Aug;80(2):314-23
pubmed: 2546698
Respir Physiol Neurobiol. 2012 Oct 15;184(1):73-9
pubmed: 22884972
Lancet. 2002 Aug 10;360(9331):473-82
pubmed: 12241736
Arch Pediatr Adolesc Med. 2010 Sep;164(9):852-9
pubmed: 20819968
Sports Med. 2013 Jul;43(7):591-600
pubmed: 23613311
Eur Heart J. 2006 Apr;27(8):954-9
pubmed: 16537555
Am J Hypertens. 2013 Feb;26(2):250-6
pubmed: 23382410
Clin Ther. 2013 Jan;35(1):A18-32
pubmed: 23328273
Sports Med. 2012 May 1;42(5):415-31
pubmed: 22455310
Clin Physiol Funct Imaging. 2012 Jul;32(4):305-9
pubmed: 22681608
Eur J Prev Cardiol. 2016 May;23(8):865-73
pubmed: 26464293
Am J Cardiol. 2015 Dec 1;116(11):1678-84
pubmed: 26482180
Int J Obes (Lond). 2006 Apr;30(4):598-602
pubmed: 16570089
J Appl Physiol (1985). 2006 May;100(5):1630-7
pubmed: 16373448
Heart. 2006 May;92(5):609-14
pubmed: 16159987
Circulation. 1997 Nov 18;96(10):3287-93
pubmed: 9396418
Pediatr Obes. 2012 Aug;7(4):284-94
pubmed: 22715120